Sentence examples for frequency of relapse from inspiring English sources

In the current study with a new cohort of Italian patients, we again found that anti-RR seropositivity was associated with increased frequency of relapse.

To determine the frequency of relapse of asthma in young adults in remission at 18 years of age, during a follow-up period of 8 years, and to identify possible prognostic markers for relapse.

In a new analysis of data from previously published studies, it is reported that there were no significant differences in the frequency of relapse within 24 h after response at 4 h, between frovatriptan 2.5 mg and sumatriptan 100 mg, which has a half-life of only 2 h [50].

The frequency of early mortality was 7%, and the frequency of relapse was 26.2%.

The SR group had a higher frequency of relapse (30.1%) and higher frequency of events (47.9%).

The highest frequency of relapse was observed in patients with leukaemia of B cell lineage (26.9%).

A priori, treatment of MS should be instituted as early as possible— before gliotic scars have developed within the central nervous system (CNS) with permanent disability as the consequence Treatment with recombinant interferon-β (rIFN-β) is beneficial in relapsing-remitting MS by reducing the frequency of relapses and decreasing the number of new lesions on magnetic resonance imaging (MRI).

Natalizumab (Tysabri), a monoclonal antibody (an antibody clone derived from a single immune cell), is also effective for controlling the severity and frequency of relapses.

The effectiveness of multiple sclerosis drugs is often judged by how much they reduce the frequency of relapses, which are severe flare-ups of symptoms, compared to a placebo in clinical trials.

The medicine, interferon beta, does help reduce the development of brain lesions and limit the frequency of relapses, but until now there have been few well-controlled long-term studies demonstrating its effectiveness at preventing the onset of irreversible disability.

In addition, there are a handful of disease-modifying agents available for MS. These agents can reduce the frequency of relapses and generally slow the progress of the disease.